Gene therapy startups push past old limits to reach more patients With gene therapy now a clinical reality, innovators are designing delivery systems that can sustain lifelong correction, handle complex genes, and make treatments accessible to more patients. +++++

https://www.drugdiscoverynews.com/gene-therapy-startups-push-past-old-limits-to-reach-more-patients-17003 In 2026, drug discovery faces a higher bar Biopharma’s recovery is real, but the data show a sector that now rewards validated biology, late-stage execution, and commercial relevance. https://www.drugdiscoverynews.com/in-2026-drug-discovery-faces-a-higher-bar-16997 A faster route to active GPCRs GPCRs drive a huge portion of today’s drug market, but producing them in a functional form remains a major bottleneck for discovery and structural studies. https://www.drugdiscoverynews.com/a-faster-route-to-active-gpcrs-16977 Exploring the tiny robots improving drug delivery from inside the body Moved by magnets or ultrasound waves, these tiny robots make delivering drugs more accurate and effective. https://www.drugdiscoverynews.com/exploring-the-tiny-robots-improving-drug-delivery-from-inside-the-body-16998 Sustained-release drug delivery targets pediatric inherited retinal disease PolyActiva and RareSight are pairing pro-drug chemistry with targeted ocular delivery to address early-stage barriers in rare pediatric retinal disorders. https://www.drugdiscoverynews.com/sustained-release-drug-delivery-targets-pediatric-inherited-retinal-disease-16945